Literature DB >> 3803742

Glycosylation of low density lipoprotein in patients with type 1 (insulin-dependent) diabetes: correlations with other parameters of glycaemic control.

T J Lyons, J W Baynes, J S Patrick, J A Colwell, M F Lopes-Virella.   

Abstract

Glycosylation of low density lipoproteins obtained from 16 patients with Type 1 (insulin-dependent) diabetes and from 16 age-, sex-, and race-matched controls, was determined. The diabetic patients were normolipaemic and were in good or fair glycaemic control. Eleven patients performed home blood glucose monitoring. Glycosylation of low density lipoproteins in the diabetic patients was significantly higher (p less than 0.001) than in the control subjects, and was significantly correlated with haemoglobin A1c, (p less than 0.01), glycosylation of plasma proteins, (p less than 0.001), and mean home blood glucose, (p less than 0.01). This study confirms that, in diabetic patients, increased glycosylation of low density lipoprotein occurs to an extent which correlates closely with other commonly used indices of glycaemic control.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3803742     DOI: 10.1007/bf00870276

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  21 in total

1.  Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study.

Authors:  M J Garcia; P M McNamara; T Gordon; W B Kannel
Journal:  Diabetes       Date:  1974-02       Impact factor: 9.461

2.  The measurement of amino groups in proteins and peptides.

Authors:  R Fields
Journal:  Biochem J       Date:  1971-09       Impact factor: 3.857

3.  Surface binding, internalization and degradation by cultured human fibroblasts of low density lipoproteins isolated from type 1 (insulin-dependent) diabetic patients: changes with metabolic control.

Authors:  M F Lopes-Virella; G K Sherer; A M Lees; H Wohltmann; R Mayfield; J Sagel; E C LeRoy; J A Colwell
Journal:  Diabetologia       Date:  1982-06       Impact factor: 10.122

4.  Glucosylation of low-density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism.

Authors:  U P Steinbrecher; J L Witztum
Journal:  Diabetes       Date:  1984-02       Impact factor: 9.461

5.  The Bedford survey: ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics.

Authors:  R J Jarrett; P McCartney; H Keen
Journal:  Diabetologia       Date:  1982-02       Impact factor: 10.122

6.  Non-enzymatic glycosylation of tissue protein in diabetes in the rat.

Authors:  D K Yue; S McLennan; J R Turtle
Journal:  Diabetologia       Date:  1983-05       Impact factor: 10.122

7.  Nonenzymatic glycosylation of low density lipoproteins in vitro. Effects on cell-interactive properties.

Authors:  B Gonen; J Baenziger; G Schonfeld; D Jacobson; P Farrar
Journal:  Diabetes       Date:  1981-10       Impact factor: 9.461

8.  Nonenzymatic glucosylation of low-density lipoprotein alters its biologic activity.

Authors:  J L Witztum; E M Mahoney; M J Branks; M Fisher; R Elam; D Steinberg
Journal:  Diabetes       Date:  1982-04       Impact factor: 9.461

9.  Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study.

Authors:  J H Fuller; M J Shipley; G Rose; R J Jarrett; H Keen
Journal:  Lancet       Date:  1980-06-28       Impact factor: 79.321

10.  Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

Authors: 
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461

View more
  20 in total

1.  Oxidised, glycated LDL selectively influences tissue inhibitor of metalloproteinase-3 gene expression and protein production in human retinal capillary pericytes.

Authors:  J L Barth; Y Yu; W Song; K Lu; A Dashti; Y Huang; W S Argraves; T J Lyons
Journal:  Diabetologia       Date:  2007-08-04       Impact factor: 10.122

2.  Tyrosine nitration of prostacyclin synthase is associated with enhanced retinal cell apoptosis in diabetes.

Authors:  Ming-Hui Zou; Hongliang Li; Chaoyong He; Mingkai Lin; Timothy J Lyons; Zhonglin Xie
Journal:  Am J Pathol       Date:  2011-10-18       Impact factor: 4.307

3.  Non-enzymatic glycosylation of low-density lipoprotein. Results of an affinity chromatography method.

Authors:  C M Jack; B Sheridan; L Kennedy; R W Stout
Journal:  Diabetologia       Date:  1988-02       Impact factor: 10.122

Review 4.  Lipoprotein alterations in diabetes mellitus.

Authors:  G M Kostner; I Karádi
Journal:  Diabetologia       Date:  1988-10       Impact factor: 10.122

5.  Mechanisms of modified LDL-induced pericyte loss and retinal injury in diabetic retinopathy.

Authors:  D Fu; M Wu; J Zhang; M Du; S Yang; S M Hammad; K Wilson; J Chen; T J Lyons
Journal:  Diabetologia       Date:  2012-08-31       Impact factor: 10.122

Review 6.  Impact and mechanism for oxidized and glycated lipoproteins on generation of fibrinolytic regulators from vascular endothelial cells.

Authors:  Garry X Shen
Journal:  Mol Cell Biochem       Date:  2003-04       Impact factor: 3.396

7.  A review of glycated albumin as an intermediate glycation index for controlling diabetes.

Authors:  H Vernon Roohk; Asad R Zaidi
Journal:  J Diabetes Sci Technol       Date:  2008-11

8.  Inhibiting low-density lipoprotein glycation ameliorates increased cholesteryl ester synthesis in macrophages and hypercholesterolemia and aortic lipid peroxidation in streptozotocin diabetic rats.

Authors:  Margo P Cohen; Elizabeth A Shea; Van-Yu Wu
Journal:  Metabolism       Date:  2009-11-18       Impact factor: 8.694

9.  Impact of in vivo glycation of LDL on platelet aggregation and monocyte chemotaxis in diabetic psammomys obesus.

Authors:  Monika Zoltowska; Edgard Delvin; Ehud Ziv; Noel Peretti; Manon Chartré; Emile Levy
Journal:  Lipids       Date:  2004-01       Impact factor: 1.880

10.  Effect of glycated LDL on microvascular tone in mice: a comparative study with LDL modified in vitro or isolated from diabetic patients.

Authors:  P Nivoit; N Wiernsperger; P Moulin; M Lagarde; C Renaudin
Journal:  Diabetologia       Date:  2003-10-24       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.